ANDA 83524, held by Marshall Pharma. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 83524 (Sodium Butabarbital), held by Marshall Pharma, was first approved by FDA on Jan 15, 1974, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 15, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sodium Butabarbital16.2MG ยท tablet;oral | Butabarbital Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters